NASDAQ: BMRN       Biomarin Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
86.59   +0.70 (0.81%)  86.09 - 87.08  259,482


Avg Volume (4 weeks):1,377,016
4 Weeks Range:82.82 - 93.14
4 Weeks Price Volatility (%):
52 Weeks Range:62.88 - 100.13
52 Weeks Price Volatility (%):
Average Price Target: 133.00
Price Target Upside/Downside: +46.41


No recent Headlines for this stock.

Business Background

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

  Be the first to like this.


2059  3360  565  2980 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACHN 6.760.00 
 GE 12.965+1.235 
 AVP 5.60-0.05 
 AMD 46.879-3.651 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 CHK 0.544+0.026 
 BBT 54.24+0.75 
Partners & Brokers